Aribi A - Search Results

1

Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer.

Pourhassan H, Zhang J, Tinajero J, Pullarkat V, Agrawal V, Koller P, Al Malki M, Aribi A, Salhotra A, Sandhu K, Ali H, Stein A, Marcucci G, Forman S, Aldoss I. Pourhassan H, et al. Among authors: aribi a. Br J Haematol. 2024 Jul;205(1):158-165. doi: 10.1111/bjh.19432. Epub 2024 Mar 31. Br J Haematol. 2024. PMID: 38556836

2

Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome.

Kantarjian HM, O'Brien S, Shan J, Aribi A, Garcia-Manero G, Jabbour E, Ravandi F, Cortes J, Davisson J, Issa JP. Kantarjian HM, et al. Among authors: aribi a. Cancer. 2007 Jan 15;109(2):265-73. doi: 10.1002/cncr.22376. Cancer. 2007. PMID: 17133405 Free article. Clinical Trial.

3

Novel approaches in the treatment of systemic mastocytosis.

Quintas-Cardama A, Aribi A, Cortes J, Giles FJ, Kantarjian H, Verstovsek S. Quintas-Cardama A, et al. Among authors: aribi a. Cancer. 2006 Oct 1;107(7):1429-39. doi: 10.1002/cncr.22187. Cancer. 2006. PMID: 16948123 Free article. Review.

4

The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

Aribi A, Kantarjian H, Koller C, Thomas D, Faderl S, Garcia-Manero G, Cortes J. Aribi A, et al. Cancer. 2008 Sep 15;113(6):1338-43. doi: 10.1002/cncr.23718. Cancer. 2008. PMID: 18629842 Free article.

5

Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.

Ravandi F, Aribi A, O'Brien S, Faderl S, Jones D, Ferrajoli A, Huang X, York S, Pierce S, Wierda W, Kontoyiannis D, Verstovsek S, Pro B, Fayad L, Keating M, Kantarjian H. Ravandi F, et al. Among authors: aribi a. J Clin Oncol. 2009 Nov 10;27(32):5425-30. doi: 10.1200/JCO.2009.22.6688. Epub 2009 Oct 5. J Clin Oncol. 2009. PMID: 19805674 Free PMC article. Clinical Trial.

6

Novel agents in acute myeloid leukemia.

Aribi A, Ravandi F, Giles F. Aribi A, et al. Cancer J. 2006 Mar-Apr;12(2):77-91. Cancer J. 2006. PMID: 16630396 Review.

7

Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia.

Aribi A, Borthakur G, Ravandi F, Shan J, Davisson J, Cortes J, Kantarjian H. Aribi A, et al. Cancer. 2007 Feb 15;109(4):713-7. doi: 10.1002/cncr.22457. Cancer. 2007. PMID: 17219444 Free article.

8

Effects of glial toxins on extracellular acidification in the hippocampal CA1 region in vivo.

Stringer JL, Aribi AM. Stringer JL, et al. Epilepsy Res. 2003 May;54(2-3):163-70. doi: 10.1016/s0920-1211(03)00064-0. Epilepsy Res. 2003. PMID: 12837567

9

Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumab ozogamicin in recurrent acute promyelocytic leukemia.

Aribi A, Kantarjian HM, Estey EH, Koller CA, Thomas DA, Kornblau SM, Faderl SH, Laddie NM, Garcia-Manero G, Cortes JE. Aribi A, et al. Cancer. 2007 Apr 1;109(7):1355-9. doi: 10.1002/cncr.22524. Cancer. 2007. PMID: 17326049 Free article.

10

Effects of antiepileptic drugs on extracellular pH regulation in the hippocampal CA1 region in vivo.

Aribi AM, Stringer JL. Aribi AM, et al. Epilepsy Res. 2002 Apr;49(2):143-51. doi: 10.1016/s0920-1211(02)00019-0. Epilepsy Res. 2002. PMID: 12049802

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters